Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative Review

Endometrial carcinoma is one of the important health issues addressed globally. Therefore, understanding the molecular pathogenesis of endometrial carcinoma for the purpose of prognostic and predictive markers remains in the centre of research. It has been reported in recently published literature t...

Full description

Saved in:
Bibliographic Details
Main Authors: Garima Chandrakar, Arvind Bhake
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2025-01-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
Online Access:https://jcdr.net/articles/PDF/20482/75346_CE[Ra1]_F(SHU)_QC(SD_SS)_PF1(AG_OM)_PFA(SS)_PB(AG_IS)_PN(IS).pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841527582011424768
author Garima Chandrakar
Arvind Bhake
author_facet Garima Chandrakar
Arvind Bhake
author_sort Garima Chandrakar
collection DOAJ
description Endometrial carcinoma is one of the important health issues addressed globally. Therefore, understanding the molecular pathogenesis of endometrial carcinoma for the purpose of prognostic and predictive markers remains in the centre of research. It has been reported in recently published literature that loss of Phosphatase and Tensin Homolog (PTEN) expression, a tumour suppressor gene, is one of the key events in the pathogenesis of endometrial carcinoma. This review aims to study the data for loss of PTEN expression in literature. Based on the inclusion and exclusion criteria, eight studies were finally included in the review. Comparative statistics of various studies showed that loss of PTEN expression is a key molecular event in endometrial carcinoma. The detection of lost PTEN expression could help in knowing the progressive nature of Atypical Endometrial Hyperplasia (AEH) and in distinguishing AEH from endometrial carcinoma. This will facilitate the choice of targeted therapy.
format Article
id doaj-art-0ea5e423f6ac46349dcdb97bfbd74db2
institution Kabale University
issn 2249-782X
0973-709X
language English
publishDate 2025-01-01
publisher JCDR Research and Publications Private Limited
record_format Article
series Journal of Clinical and Diagnostic Research
spelling doaj-art-0ea5e423f6ac46349dcdb97bfbd74db22025-01-15T11:45:05ZengJCDR Research and Publications Private LimitedJournal of Clinical and Diagnostic Research2249-782X0973-709X2025-01-011901050710.7860/JCDR/2025/75346.20482Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative ReviewGarima Chandrakar0Arvind Bhake1Junior Resident, Department of Pathology, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha, Maharashtra, India.Director Professor, Department of Pathology, Jawaharlal Nehru Medical College, Sawangi Meghe, Wardha, Maharashtra, India.Endometrial carcinoma is one of the important health issues addressed globally. Therefore, understanding the molecular pathogenesis of endometrial carcinoma for the purpose of prognostic and predictive markers remains in the centre of research. It has been reported in recently published literature that loss of Phosphatase and Tensin Homolog (PTEN) expression, a tumour suppressor gene, is one of the key events in the pathogenesis of endometrial carcinoma. This review aims to study the data for loss of PTEN expression in literature. Based on the inclusion and exclusion criteria, eight studies were finally included in the review. Comparative statistics of various studies showed that loss of PTEN expression is a key molecular event in endometrial carcinoma. The detection of lost PTEN expression could help in knowing the progressive nature of Atypical Endometrial Hyperplasia (AEH) and in distinguishing AEH from endometrial carcinoma. This will facilitate the choice of targeted therapy.https://jcdr.net/articles/PDF/20482/75346_CE[Ra1]_F(SHU)_QC(SD_SS)_PF1(AG_OM)_PFA(SS)_PB(AG_IS)_PN(IS).pdfatypical endometrial hyperplasiaimmunohistochemistrytumour suppressor gene
spellingShingle Garima Chandrakar
Arvind Bhake
Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative Review
Journal of Clinical and Diagnostic Research
atypical endometrial hyperplasia
immunohistochemistry
tumour suppressor gene
title Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative Review
title_full Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative Review
title_fullStr Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative Review
title_full_unstemmed Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative Review
title_short Loss of PTEN Immunoexpression in Endometrial Carcinoma: A Narrative Review
title_sort loss of pten immunoexpression in endometrial carcinoma a narrative review
topic atypical endometrial hyperplasia
immunohistochemistry
tumour suppressor gene
url https://jcdr.net/articles/PDF/20482/75346_CE[Ra1]_F(SHU)_QC(SD_SS)_PF1(AG_OM)_PFA(SS)_PB(AG_IS)_PN(IS).pdf
work_keys_str_mv AT garimachandrakar lossofptenimmunoexpressioninendometrialcarcinomaanarrativereview
AT arvindbhake lossofptenimmunoexpressioninendometrialcarcinomaanarrativereview